AstraZeneca pledges $15 billion China investment during Starmer trip
Briefly

AstraZeneca pledges $15 billion China investment during Starmer trip
"British pharmaceutical giant AstraZeneca has pledged a $15 billion investment in China by 2030, aiming to expand its medicines manufacturing and research and development capabilities. The announcement, made on Thursday during Prime Minister Keir Starmer's visit to Beijing, marks the largest deal of his trip as Britain seeks to strengthen ties with China amid strained relations with Washington. Prime Minister Starmer welcomed the investment, stating: "AstraZeneca's expansion and leadership in China will help the British manufacturer continue to grow - supporting thousands of UK jobs.""
"From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging."
The Independent emphasizes on-the-ground reporting across topics like reproductive rights, climate change, and Big Tech and keeps reporting free by relying on donations rather than paywalls. Donations fund journalists to report both sides and produce documentaries such as 'The A Word'. British pharmaceutical giant AstraZeneca pledged a $15 billion investment in China by 2030 to expand medicines manufacturing and research and development. The pledge was announced during Prime Minister Keir Starmer's Beijing visit and was described as the largest deal of his trip. The investment follows a $50 billion US manufacturing deal and comes despite recent scandals, including the 2024 arrest of AstraZeneca's China president.
Read at www.independent.co.uk
Unable to calculate read time
[
|
]